Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cencora (COR) Common Equity (2016 - 2025)

Historic Common Equity for Cencora (COR) over the last 17 years, with Q4 2025 value amounting to $2.1 billion.

  • Cencora's Common Equity rose 47915.35% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 billion, marking a year-over-year increase of 47915.35%. This contributed to the annual value of $1.7 billion for FY2025, which is 12206.58% up from last year.
  • Cencora's Common Equity amounted to $2.1 billion in Q4 2025, which was up 47915.35% from $1.7 billion recorded in Q3 2025.
  • In the past 5 years, Cencora's Common Equity ranged from a high of $2.2 billion in Q2 2025 and a low of -$281.8 million during Q1 2021
  • Over the past 5 years, Cencora's median Common Equity value was $726.5 million (recorded in 2023), while the average stood at $835.5 million.
  • As far as peak fluctuations go, Cencora's Common Equity plummeted by 10760.45% in 2021, and later soared by 134272.76% in 2023.
  • Quarter analysis of 5 years shows Cencora's Common Equity stood at $601.1 million in 2021, then plummeted by 87.76% to $73.6 million in 2022, then surged by 1342.73% to $1.1 billion in 2023, then crashed by 65.9% to $361.9 million in 2024, then skyrocketed by 479.15% to $2.1 billion in 2025.
  • Its Common Equity stands at $2.1 billion for Q4 2025, versus $1.7 billion for Q3 2025 and $2.2 billion for Q2 2025.